Try a new search

Format these results:

Searched for:

person:seminn01

Total Results:

13


Acute Alopecia Associated With Albendazole Toxicosis [Letter]

Curtiss, Paul; Cobos, Gabriela; Sicco, Kristen Lo; Seminara, Nicole
PMID: 35856765
ISSN: 2326-6929
CID: 5278612

Comparison between organismal staining on histology and tissue culture in the diagnosis of cutaneous infection: a retrospective study

Shaigany, Sheila; Steuer, Alexa; Seminara, Nicole; Brinster, Nooshin; Femia, Alisa
BACKGROUND:In instances of suspected cutaneous infection, standard of care includes obtaining skin biopsies for histology and tissue culture. Few studies have compared the clinical utility of each test. OBJECTIVE:To assess the concordance of results between tissue culture and histology, and clinicopathologic features that may influence the diagnostic yield of each test. METHODS:A retrospective review of all patients who underwent skin biopsy for histology and tissue culture at New York University from 2013-2018. RESULTS:Of 179 patients, 10% had positive concordance, 21% had positive tissue culture only, and 7% had positive histology only. We calculated a kappa correlation coefficient of 0.25 between histology and tissue culture [ref 0.21-0.39=minimal agreement]. Histology exhibited higher sensitivity in detecting fungi, whereas tissue culture was more sensitive in identifying gram-negative bacteria. Antimicrobial use prior to biopsy led to significantly fewer positive cultures (37.5% versus 71%; p=0.023) in patients ultimately diagnosed with infection. LIMITATIONS/CONCLUSIONS:This study was conducted at a single institution thereby restricting its broad applicability. The lack of a validated gold standard to diagnose infection also limits interpretation of results. CONCLUSION/CONCLUSIONS:Tissue culture and histopathology often yield discordant results. Dermatologists should recognize specific test limitations, yet high clinical utility in special circumstances, when approaching cases of suspected infection.
PMID: 32004643
ISSN: 1097-6787
CID: 4294442

Genital ulcers in an immunocompromised man

Curtiss, Paul; Cobos, Gabriela; Hoffmann, Rachel; Seminara, Nicole; Liebman, Tracey; Brinster, Nooshin; Lo Sicco, Kristen
PMCID:6070680
PMID: 30094299
ISSN: 2352-5126
CID: 3226252

An immunosuppressed man with an isolated necrotic plaque on the chest

Berk-Krauss, Juliana; Hoffmann, Rachel; Mu, Euphemia; Kim, Randie; Seminara, Nicole; Lo Sicco, Kristen I; Liebman, Tracey N
PMCID:5767909
PMID: 29349112
ISSN: 2352-5126
CID: 2915272

Unravelling the links between malignancy, cytokines and neutrophilic eruptions

Seminara, N M; Pomeranz, M K
PMID: 29052904
ISSN: 1365-2133
CID: 2742262

Dermatomyositis, clinically presenting with cutaneous ulcers, with histopathologic evidence of perforating collagenosis

Rosenstein, Rachel; Martires, Kathryn; Christman, Mitalee; Terushkin, Vitaly; Meehan, Shane A; Seminara, Nicole; Golden, Brian D; Franks, Andrew G Jr
Dermatomyositis is a systemic, autoimmune diseasewith a variety of clinical features that often includemyositis and characteristic cutaneous findings. Asubset of patients with dermatomyositis developcutaneous ulcers, often in the setting of vasculitis orvasculopathy. We present a case of dermatomyositiswith cutaneous ulcers that show perforatingcollagenosis on histopathologic examination.Acquired reactive perforating collagenosistypically occurs in the setting of diabetes mellitus,chronic renal failure, and other pruritic conditions,and this case represents a rare association withdermatomyositis, which may ultimately be helpful inelucidating the pathophysiology of this perforatingdisorder.
PMID: 28329555
ISSN: 1087-2108
CID: 2494812

Aberrant Lymphatic Drainage and Risk for Melanoma Recurrence after Negative Sentinel Node Biopsy in Middle-aged and Older Men

Kaveh, Anthony H; Seminara, Nicole M; Barnes, Melynda A; Berger, Aaron J; Chen, Frank W; Yao, Mike; Johnson, Denise; Parsa, Sean; Quon, Andrew; Swetter, Susan M; Sunwoo, John B
Background Aberrant lymphatic drainage is believed to contribute to the high recurrence rate of head and neck melanomas. This study aimed to identify the clinical significance of unexpected lymphatic drainage patterns. Methods A single institution retrospective analysis was performed of middle-aged and older males (mean age 66.2 years, range 41-87 years) who underwent successful lymphoscintigraphy with sentinel node (SLN) biopsy from 1997 through 2012. Node status, distribution, and recurrence were assessed comparing patients with expected and unexpected drainage patterns. Results Sixty-six patients were identified with 55.8 months median follow-up (range 5.6-206.1 months). Unexpected SLN drainage was associated with multiple basin drainage (p < 0.01) and greater recurrence after negative SLN biopsy (p = 0.03). Both groups had similar anatomic distribution, SLN sampling, histopathologic characteristics, follow-up, and survival. Conclusion Lymphatic drainage differing from expected patterns is associated with greater recurrence after negative SLN biopsy in middle-aged and older males
PMID: 25914266
ISSN: 1097-0347
CID: 1647752

A potential role for the dermatologist in the physical transformation of transgender people: A survey of attitudes and practices within the transgender community

Ginsberg, Brian A; Calderon, Marcus; Seminara, Nicole M; Day, Doris
BACKGROUND: There are an estimated 700,000 or more transgender people in the United States, however their dermatologic needs are not fully established in the medical literature. Unique needs relate to hormone therapy, prior surgeries, and other aspects of physical transitioning. OBJECTIVES: By examining attitudes and practices of transgender individuals, we aimed to identify areas for which dermatologists could contribute to their physical transformation. METHODS: This cross-sectional study used an anonymous online survey, distributed via lesbian, gay, bisexual, and transgender organizations; social media; and at targeted locations and events. RESULTS: A total of 327 people completed the survey (63% men, 29% women, 9% other). Most transgender women indicated that their face was most imperative to have changed, whereas men noted their chest, in turn influencing procedures. Of women's facial procedures, hair removal predominated, followed by surgery then injectables, mostly performed by plastic surgeons. Hormone-induced facial effects varied, usually taking over 2 years for maximal effect. When choosing procedures, money was the major barrier and good aesthetic outcome the primary concern. Participants did not think that facial procedures necessitate the currently accepted prerequisites for chest and genital surgery. LIMITATIONS: This study has limited size and convenience sampling. CONCLUSION: Dermatologists could contribute to the physical transformation of transgender patients through noninvasive procedures.
PMID: 26669479
ISSN: 1097-6787
CID: 1877912

Prevalence and treatment patterns of psoriatic arthritis in the UK

Ogdie, Alexis; Langan, Sinead; Love, Thorvardur; Haynes, Kevin; Shin, Daniel; Seminara, Nicole; Mehta, Nehal N; Troxel, Andrea; Choi, Hyon; Gelfand, Joel M
OBJECTIVES: The objectives of this study were to determine the prevalence of PsA in The Health Improvement Network (THIN), a large population-based medical records database in the UK, to examine factors associated with prevalent PsA among patients with psoriasis and to describe the use of DMARDs in patients with PsA. METHODS: Two cohorts were derived from THIN to examine the prevalence of PsA in a cross-sectional study among all patients aged 18-90 years and among a subcohort of 4900 psoriasis patients aged 45-65 years. Prescription codes were used to describe therapies after the diagnosis of PsA. Associations for prevalent PsA among psoriasis patients were assessed using logistic regression analysis. RESULTS: Among 4.8 million patients in THIN between the ages of 18 and 90 years, 9045 patients had at least one medical code for PsA, giving an overall prevalence of 0.19% (95% CI 0.19%, 0.19%). Of those patients, 45.9% with PsA have been prescribed DMARDs. Among the 4064 confirmed psoriasis patients, the prevalence of PsA was 8.6% (95% CI 7.7%, 9.5%). PsA was more prevalent among patients with severe psoriasis [odds ratio (OR) 3.34; 95% CI 2.40, 4.65], obesity (OR 1.77; 95% CI 1.30, 2.41) and duration of psoriasis for >/=10 years (OR 7.42; 95% CI 3.86, 14.25) in the fully adjusted model. CONCLUSION: The prevalence of PsA in THIN is consistent with previous population-based estimates. Limitations include a definition of PsA based on a diagnostic code rather than Classification Criteria for Psoriatic Arthritis (CASPAR) criteria. Given the large population of PsA patients, THIN is an important resource for the study of PsA.
PMCID:3573270
PMID: 23221331
ISSN: 1462-0332
CID: 1647802

Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis

Azfar, Rahat S; Seminara, Nicole M; Shin, Daniel B; Troxel, Andrea B; Margolis, David J; Gelfand, Joel M
OBJECTIVE: To assess the risk of incident diabetes mellitus (DM) in patients with psoriasis and to evaluate DM treatment patterns among patients with psoriasis and incident DM. DESIGN: Population-based cohort study. SETTING: United Kingdom-based electronic medical records. PATIENTS: We matched 108 132 patients with psoriasis aged 18 to 90 years with 430 716 unexposed patients based on practice and time of visit. For our nested study, only patients who developed incident DM during our study time were included. MAIN OUTCOME MEASURES: Incident DM and adjusted risk of pharmacotherapy among those with incident DM. RESULTS: The fully adjusted hazard ratios (95% CIs) for incident DM were 1.14 (95% CI, 1.10-1.18), 1.11 (95% CI, 1.07-1.15), and 1.46 (95% CI, 1.30-1.65) in the overall, mild, and severe psoriasis groups, respectively. Among those with incident DM and severe psoriasis, the adjusted risk for receiving DM pharmacotherapy was 1.55 (95% CI, 1.15-2.10). CONCLUSIONS: Our results suggest that psoriasis is an independent risk factor for the development of type 2 DM in a dose-dependent manner, and that patients with severe psoriasis who develop DM are more likely to receive systemic diabetic therapies in comparison with patients with DM but without psoriasis.
PMCID:3677207
PMID: 22710320
ISSN: 1538-3652
CID: 1647762